CDK Inhibitors

CDK1

CDK2

CDK3

CDK4

CDK5

CDK6

CDK7

CDK8

CDK9

CDK11

CDK12

CDK13

CDK14

CDK16

CDK19

CDC

CLK

Pho85

CDK10

CDK15

CDK17

CDK18

CDK20

PITSLRE

CDK Inhibitors, Agonists, Antagonists, Activators, Modulators, Degraders & Ligands

Product Name	CDK1	CDK2	CDK3	CDK4	CDK5	CDK6	CDK7	CDK8	CDK9	CDK11	CDK12	CDK13	CDK14	CDK16	CDK19	CDC	CLK	Pho85	CDK10	CDK15	CDK17	CDK18	CDK20	PITSLRE	Purity
Palbociclib				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM																			99.94%
Abemaciclib	CDK1/cyclinB1, IC₅₀: 1627 nM	CDK2/cyclinE, IC₅₀: 504 nM		Cdk4/cyclin D1, IC₅₀: 2 nM	CDK5/p35, IC₅₀: 287 nM Cdk5/p25, IC₅₀: 355 nM	CDK6/cyclinD1, IC₅₀: 10 nM	CDK7/Mat1/cyclinH1, IC₅₀: 3910 nM		CDK9/cyclinT1, IC₅₀: 57 nM																99.97%
Ro-3306	CDK1, Ki: 20 nM CDK1/cyclinB1, Ki: 35 nM CDK1/cyclin A, Ki: 110 nM	CDK2/cyclinE, Ki: 340 nM																							99.83%
Dabrafenib																					CDK17				99.94%
Ribociclib				CDK4, IC₅₀: 10 nM		CDK6, IC₅₀: 39 nM																			99.94%
Q901 TFA							CDK7, IC₅₀: 10 nM
Ironomycin				CDK4/cyclin D2 Cdk4/cyclin D1																					99.53%
OP-3136				CDK4		CDK6
Dinaciclib	CDK1, IC₅₀: 3 nM	CDK2, IC₅₀: 1 nM			CDK5, IC₅₀: 1 nM				CDK9, IC₅₀: 4 nM																99.80%
Flavopiridol	CDK1/Cyc B1, IC₅₀: 30 nM	CDK2/Cyc E, IC₅₀: 170 nM		CDK4/Cyc D1, IC₅₀: 100 nM																					99.72%
Palbociclib hydrochloride				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM																			99.96%
GSK3326595				CDK4		CDK6																			99.83%
(R)-Roscovitine	cdc2/cyclin B, IC₅₀: 0.65 μM	cdk2/cyclin A, IC₅₀: 0.7 μM Cdk2/cyclin E2, IC₅₀: 0.7 μM			CDK5/p35, IC₅₀: 0.16 μM																				99.53%
THZ1							CDK7, IC₅₀: 3.2 nM																		99.84%
Tagtociclib hydrate		CDK2/cyclin E1, Ki: 1.16 nM																							99.73%
Palbociclib monohydrochloride				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM																			99.98%
AZD4573									CDK9, IC₅₀: 4 nM																99.98%
Palbociclib isethionate				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM																			99.98%
Abemaciclib methanesulfonate	CDK1/cyclinB1, IC₅₀: 1627 nM	CDK2/cyclinE, IC₅₀: 504 nM		Cdk4/cyclin D1, IC₅₀: 2 nM	Cdk5/p25, IC₅₀: 355 nM CDK5/p35, IC₅₀: 287 nM	CDK6/cyclinD1, IC₅₀: 10 nM	CDK7/Mat1/cyclinH1, IC₅₀: 3910 nM		CDK9/cyclinT1, IC₅₀: 57 nM																99.95%
Wogonin								CDK8																	99.83%
SNS-032	CDK1, IC₅₀: 480 nM	CDK2, IC₅₀: 38 nM		CDK4, IC₅₀: 925 nM			CDK7, IC₅₀: 62 nM		CDK9, IC₅₀: 4 nM																99.91%
THZ531							CDK7, IC₅₀: 8.5 μM		CDK9, IC₅₀: 10.5 μM		CDK12, IC₅₀: 158 nM	CDK13, IC₅₀: 69 nM													99.86%
SY-5609		CDK2, Ki: 2600 nM					CDK7, Kd: 0.065 nM		CDK9, Ki: 960 nM		CDK12, Ki: 870 nM														99.93%
Kenpaullone	Cdk1/cyclin B, IC₅₀: 0.4 μM	cdk2/cyclin A, IC₅₀: 0.68 μM CDK2/cyclinE, IC₅₀: 7.5 μM			Cdk5/p25, IC₅₀: 0.85 μM																				98.20%
hSMG-1 inhibitor 11j	CDK1, IC₅₀: 32 μM	CDK2, IC₅₀: 7.1 μM																							99.82%
SR-4835											CDK12, IC₅₀: 99 nM CDK12, Kd: 98 nM	CDK13, Kd: 4.9 nM													99.73%
NVP-2									CDK9, IC₅₀: 0.5 nM																99.05%
GSK 3 Inhibitor IX	Cdk1/cyclin B, IC₅₀: 320 nM	cdk2/cyclin A, IC₅₀: 300 nM		Cdk4/cyclin D1, IC₅₀: 10 μM	CDK5/p35, IC₅₀: 80 nM																				99.73%
OTS964 hydrochloride										CDK11B, Kd: 40 nM															99.74%
Samuraciclib hydrochloride	CDK1, IC₅₀: 1.8 μM	CDK2, IC₅₀: 578 nM		CDK4, IC₅₀: 49 μM	CDK5, IC₅₀: 9.4 μM	CDK6, IC₅₀: 34 μM	CDK7, IC₅₀: 41 nM		CDK9, IC₅₀: 1.2 μM																99.98%
Toyocamycin		CDK2/cyclinA, IC₅₀: 0.67 μM		Cdk4/cyclin D3, IC₅₀: 15 μM		cdk6/cyclin D3, IC₅₀: >10 μM	CDK7/Mat1/cyclinH1, IC₅₀: 2.8 μM		CDK9/cyclinT1, IC₅₀: 79 nM																99.27%
Amantadine		CDK2																							99.90%
BI-1347								CDK8, IC₅₀: 1.1 nM																	99.85%
Simurosertib																Cdc7, IC₅₀: <0.3 nM									99.94%
YKL-5-124		CDK2, IC₅₀: 1300 nM					CDK7, IC₅₀: 53.5 nM CDK7/Mat1/CycH, IC₅₀: 9.7 nM		CDK9, IC₅₀: 3020 nM																99.53%
AS2863619								CDK8, IC₅₀: 0.61 nM							CDK19, IC₅₀: 4.28 nM										98.02%
BSJ-4-116											CDK12, IC₅₀: 6 nM														99.87%
TG003																	CLK1, IC₅₀: 20 nM CLK2, IC₅₀: 200 nM CLK4, IC₅₀: 15 nM								99.57%
Tambiciclib	Cdk1/cyclin B, IC₅₀: 5410 nM	cdk2/cyclin A, IC₅₀: 6850 nM	CDK3/cyclin E1, IC₅₀: >10000 nM		Cdk5/p25, IC₅₀: 6950 nM		CDK7/Cyclin H/MNAT1, IC₅₀: 3700 nM	CDK8/cyclin C, IC₅₀: >10000 nM	CDK9, IC₅₀: 1 nM	CDK11, IC₅₀: >10000 nM			CDK14/Cyclin Y, IC₅₀: 2710 nM	CDK16/Cyclin Y, IC₅₀: 195 nM											99.21%
Enitociclib									CDK9/CycT1, IC₅₀: 3 nM																99.89%
AT7519	Cdk1/cyclin B, IC₅₀: 210 nM	cdk2/cyclin A, IC₅₀: 47 nM		Cdk4/cyclin D1, IC₅₀: 100 nM	CDK5/p35, IC₅₀: 13 nM	cdk6/cyclin D3, IC₅₀: 170 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2400 nM		CDK9/Cyclin T, IC₅₀: 10 nM																99.69%
JNJ-7706621	Cdk1/cyclin B, IC₅₀: 9 nM	CDK2/cyclinE, IC₅₀: 3 nM cdk2/cyclin A, IC₅₀: 4 nM	CDK3/Cyclin E, IC₅₀: 58 nM	Cdk4/cyclin D1, IC₅₀: 253 nM		CDK6/cyclinD1, IC₅₀: 175 nM																			99.39%
CVT-313	Cdk1/cyclin B, IC₅₀: 4.2 μM	cdk2/cyclin A, IC₅₀: 0.5 μM		Cdk4/cyclin D1, IC₅₀: 215 μM																					99.90%
CPS2		CDK2, IC₅₀: 24 nM																							99.33%
MBQ-167																Cdc42, IC₅₀: 78 nM									99.85%
Ribociclib hydrochloride				CDK4, IC₅₀: 10 nM		CDK6, IC₅₀: 39 nM																			99.95%
Ribociclib succinate				CDK4, IC₅₀: 10 nM		CDK6, IC₅₀: 39 nM																			99.93%
Fadraciclib		CDK2							CDK9																99.77%
Ebvaciclib		CDK2, Ki: 0.09 nM		CDK4, Ki: 0.13 nM		CDK6, Ki: 0.16 nM																			99.98%
Romaciclib monohydrochloride								CDK8/CycC, IC₅₀: 4.4 nM	CDK9/cycT, IC₅₀: 1070 nM						CDK19/CycC, IC₅₀: 10.4 nM										99.29%
AZD-5438	cdk1-cyclin B1, IC₅₀: 16 nM	cdk2-cyclin E, IC₅₀: 6 nM cdk2-cyclin A, IC₅₀: 45 nM		cdk4-cyclin D1, IC₅₀: 449 nM	cdk5-p25, IC₅₀: 14 nM	cdk6-cyclin D3, IC₅₀: 21 nM	cdk7-cyclin H, IC₅₀: 821 nM		cdk9-cyclin T, IC₅₀: 20 nM																99.91%
BSJ-03-204				CDK4/D1, IC₅₀: 26.9 nM		CDK6/D1, IC₅₀: 10.4 nM																			99.76%
SLK/STK10-IN-1																	CLK2, IC₅₀: 39 nM								99.78%
Flavopiridol Hydrochloride	CDK1/Cyc B1, IC₅₀: 30 nM	CDK2/Cyc E, IC₅₀: 170 nM		CDK4/Cyc D1, IC₅₀: 100 nM																					99.73%
CLK-IN-T3																	CLK1, IC₅₀: 0.67 nM CLK2, IC₅₀: 15 nM CLK3, IC₅₀: 110 nM								99.78%
BTX-A51							CDK7, Kd: 1.3 nM		CDK9, Kd: 4 nM																98.58%
Anti-IL11 Antibody (X203)	CDK1																								98.53%
Senexin B								CDK8, Kd: 140 nM							CDK19, Kd: 80 nM										99.09%
Senexin A								CDK8, Kd: 0.83 μM CDK8, IC₅₀: 280 nM							CDK19, Kd: 0.31 μM										99.58%
NG 52	cdc2-cyclin B, IC₅₀: 0.34 μM				Pho85p, IC₅₀: 2 nM																				99.88%
MSC2530818								CDK8, IC₅₀: 2.6 nM																	99.62%
(R)-CR8	Cdk1/cyclin B, IC₅₀: 0.09 μM	cdk2/cyclin A, IC₅₀: 0.072 μM CDK2/cyclinE, IC₅₀: 0.041 μM			Cdk5/p25, IC₅₀: 0.11 μM		CDK7/cyclin H, IC₅₀: 1.1 μM		CDK9/Cyclin T, IC₅₀: 0.18 μM																99.52%
Nimbolide				CDK4		CDK6																			99.79%
XO44	CDK1	CDK2		CDK4																					99.38%
hSMG-1 inhibitor 11e	CDK1, IC₅₀: 32 μM	CDK2, IC₅₀: 7.1 μM																							99.94%
Mevociclib							CDK7																		99.73%
Dalpiciclib				CDK4, IC₅₀: 12.4 nM		CDK6, IC₅₀: 9.9 nM																			99.70%
NU6300		CDK2																							98.44%
Rogocekib																	CLK2, IC₅₀: 1.4 nM								98.15%
Amantadine hydrochloride		CDK2																							98.0%
KB-0742	CDK1/cyclin A, IC₅₀: 2980 nM	cdk2/cyclin A, IC₅₀: 397 nM	CDK3/Cyclin E, IC₅₀: 1420 nM	Cdk4/cyclin D1, IC₅₀: 3130 nM	Cdk5/p25, IC₅₀: 1820 nM	CDK6/cyclinD1, IC₅₀: 3950 nM	CDK7/cyclin H, IC₅₀: 1510 nM		CDK9/cyclinT1, IC₅₀: 6 nM																99.63%
XL413																Cdc7, IC₅₀: 3.4 nM									99.02%
AUZ 454		CDK2(C118L/A144C), Kd: 9.7 nM CDK2(A144C), Kd: 15.4 nM CDK2(C118L), Kd: 18.6 nM CDK2(WT), Kd: 50 nM CDK2(C118L/A144C-Cyclin B), Kd: 134.1 nM																							99.15%
PF 477736	CDK1, Ki: 9.9 μM																								99.04%
TL12-186		cdk2/cyclin A, IC₅₀: 73 nM							CDK9/cyclinT1, IC₅₀: 55 nM																99.23%
Purvalanol A	cdc2-cyclin B, IC₅₀: 4 nM	cdk2-cyclin E, IC₅₀: 35 nM cdk2-cyclin A, IC₅₀: 70 nM		cdk4-cyclin D1, IC₅₀: 850 nM	cdk5-p35, IC₅₀: 75 nM																				98.61%
XY028-140				CDK4		CDK6																			98.52%
Thiabendazole	CCNE1	CDK2																							99.94%
BMS-265246	CDK1/cycB, IC₅₀: 6 nM	CDK2/Cyc E, IC₅₀: 9 nM		CDK4/cycD, IC₅₀: 230 nM																					99.59%
KB-0742 dihydrochloride	CDK1/cyclin A, IC₅₀: 2980 nM	cdk2/cyclin A, IC₅₀: 397 nM	CDK3/Cyclin E, IC₅₀: 1420 nM	CDK4/cyclin D, IC₅₀: 3130 nM	Cdk5/p25, IC₅₀: 1820 nM	CDK6/cyclinD1, IC₅₀: 3950 nM	CDK7/cyclin H, IC₅₀: 1510 nM	CDK8/cyclin C, IC₅₀: >10000 nM	CDK9/cyclinT1, IC₅₀: 6 nM																98.77%
Roniciclib	Cdk1/cyclin B, IC₅₀: 7 nM	CDK2/cyclinE, IC₅₀: 9 nM		CDK4/cyclin D, IC₅₀: 11 nM			CDK7/Cyclin H/MAT1, IC₅₀: 25 nM		CDK9/cyclinT1, IC₅₀: 5 nM																98.00%
PROTAC CDK2/9 Degrader-1		CDK2, DC₅₀: 62 nM							CDK9, DC₅₀: 33 nM																99.85%
Sinigrin				CDK4		CDK6																			99.97%
FMF-04-159-2		CDK2, IC₅₀: 256 nM (in NanoBRET assay)											CDK14/Cyclin Y, IC₅₀: 39.6 nM (in NanoBRET assay)												99.64%
THZ1 Hydrochloride							CDK7, IC₅₀: 3.2 nM																		99.06%
Dalpiciclib hydrochloride				CDK4, IC₅₀: 12.4 nM		CDK6, IC₅₀: 9.9 nM																			99.41%
T025																	CLK1, Kd: 4.8 nM CLK2, Kd: 0.096 nM CLK3, Kd: 6.5 nM CLK4, Kd: 0.61 nM								99.64%
CDK2 degrader 1		CDK2																							99.74%
Atuveciclib	CDK1/CycB(h), IC₅₀: 1100 nM	CDK2/CycE(h), IC₅₀: 1000 nM	CDK3/CycE(h), IC₅₀: 890 nM		CDK5/p35(h), IC₅₀: 1600 nM				CDK9/CycT1, IC₅₀: 13 nM CDK9/CycT1(h), IC₅₀: 6 nM																99.75%
BSJ-03-123						CDK6																			99.19%
CGP60474	CDK1-Cyclin B, IC₅₀: 26 nM	CDK2/cyclinE, IC₅₀: 3 nM cdk2/cyclin A, IC₅₀: 4 nM		CDK4/cyclin D, IC₅₀: 216 nM	Cdk5/p25, IC₅₀: 10 nM		CDK7/cyclin H, IC₅₀: 200 nM		CDK9/cycT, IC₅₀: 13 nM																98.90%
R547	Cdk1/cyclin B, Ki: 2 nM Cdk1/cyclin B, IC₅₀: 0.2 nM	CDK2/cyclinE, Ki: 3 nM cdk2/cyclin A, IC₅₀: 0.1 nM CDK2/cyclinE, IC₅₀: 0.4 nM	CDK3/Cyclin E, IC₅₀: 0.8 nM	CDK4/cyclin D, Ki: 1 nM	CDK5/p35, IC₅₀: 0.1 nM	cdk6/cyclin D3, IC₅₀: 4 nM	CDK7/cyclin H, IC₅₀: 171 nM																		99.57%
LDC000067	cdk1-cyclin B1, IC₅₀: 5513 nM	cdk2-cyclin A, IC₅₀: 2441 nM		cdk4-cyclin D1, IC₅₀: 9242 nM					CDK9- Cyclin T1, IC₅₀: 44 nM																99.00%
BSJ-04-132				CDK4/D1, IC₅₀: 50.6 nM		CDK6/D1, IC₅₀: 30 nM																			99.07%
Milciclib	cyclin B/CDK1, IC₅₀: 398 nM	cyclin A/CDK2, IC₅₀: 45 nM cyclin E/CDK2, IC₅₀: 363 nM		cyclin D1/CDK4, IC₅₀: 160 nM			cyclin H/CDK7, IC₅₀: 150 nM																		99.89%
Alsterpaullone	Cdk1/cyclin B, IC₅₀: 35 nM	cdk2/cyclin A, IC₅₀: 15 nM CDK2/Cyc E, IC₅₀: 200 nM			CDK5/p35, IC₅₀: 40 nM																				99.85%
PHA-793887	Cdk1/cyclin B, IC₅₀: 60 nM	cdk2/cyclin A, IC₅₀: 8 nM CDK2/cyclinE, IC₅₀: 8 nM		Cdk4/cyclin D1, IC₅₀: 62 nM	Cdk5/p25, IC₅₀: 5 nM		CDK7/cyclin H, IC₅₀: 10 nM		CDK9/cyclinT1, IC₅₀: 138 nM																99.25%
Trilaciclib hydrochloride				Cdk4/cyclin D1, IC₅₀: 1 nM		cdk6/cyclin D3, IC₅₀: 4 nM																			99.69%
SU9516	CDK1, IC₅₀: 40 nM	CDK2, IC₅₀: 22 nM		CDK4, IC₅₀: 200 nM																					99.85%
CCT-251921								CDK8, IC₅₀: 2.3 nM							CDK19, IC₅₀: 2.6 nM										99.12%
AZ5576									CDK9, : <5 nM																99.86%
RGB-286638	cyclin B1-CDK1, IC₅₀: 2 nM	cyclin E-CDK2, IC₅₀: 3 nM	cyclin E-CDK3, IC₅₀: 5 nM	cyclin D1-CDK4, IC₅₀: 4 nM	p35-CDK5, IC₅₀: 5 nM	cyclin D3-CDK6, IC₅₀: 55 nM	cyclin H-CDK7, IC₅₀: 44 nM		T1-CDK9, IC₅₀: 1 nM																99.70%
(E/Z)-Zotiraciclib		CDK2, IC₅₀: 13 nM																							99.96%
Rafutrombopag (tautomerism)				CDK4		CDK6																			98.33%
PHA-767491 hydrochloride	CDK1, IC₅₀: 250 nM	CDK2, IC₅₀: 240 nM			CDK5, IC₅₀: 460 nM				CDK9, IC₅₀: 34 nM																99.49%
Asnuciclib	CDK1, IC₅₀: 8.17 nM CDK1, Ki: 4 nM	CDK2, IC₅₀: 3.27 nM CDK2, Ki: 3 nM		CDK4, IC₅₀: 8.18 nM		CDK6, IC₅₀: 37.68 nM	CDK7, IC₅₀: 134.26 nM CDK7, Ki: 91 nM		CDK9, IC₅₀: 5.78 nM CDK9, Ki: 4 nM																99.76%
CDK2-IN-4	Cdk1/cyclin B, IC₅₀: 86 μM	cdk2/cyclin A, IC₅₀: 44 nM																							99.85%
XL413 monohydrochloride																Cdc7, IC₅₀: 3.4 nM									99.65%
Cucurbitacin E	cyclin B1/CDC2																								99.92%
GFB-12811		CDK2/CycA, IC₅₀: 211 nM			Cdk5/p25, IC₅₀: 2.3 nM	CDK6, IC₅₀: 3197 nM	CDK7/Cyclin H/MAT1, IC₅₀: 718 nM		CDK9/CycT1, IC₅₀: 894 nM																98.04%
Narazaciclib				Cdk4/cyclin D1, IC₅₀: 3.9 nM		CDK6/cyclinD1, IC₅₀: 9.82 nM																			98.66%
YJ1206											CDK12	CDK13
MeBIO	Cdk1/cyclin B, IC₅₀: 55 μM				Cdk5/p25, IC₅₀: >100 μM																				98.0%
Voruciclib	CDK1/cycB, Ki: 5.4 nM CDK1/cyc A, Ki: 9.1 nM			CDK4/Cyc D1, Ki: 3.96 nM		CDK6/cycD1, Ki: 2.92 nM			CDK9/cyc T2, Ki: 0.626 nM CDK9/CycT1, Ki: 1.68 nM																99.76%
Alisol B 23-acetate				CDK4		CDK6																			99.65%
Garcinone C							CDK7																		99.51%
(R)-CR8 trihydrochloride	CDK1/cyclinB1, IC₅₀: 0.09 μM	cdk2/cyclin A, IC₅₀: 0.072 μM CDK2/cyclinE, IC₅₀: 0.041 μM			Cdk5/p25, IC₅₀: 0.11 μM		CDK7/cyclin H, IC₅₀: 1.1 μM		CDK9/Cyclin T, IC₅₀: 0.18 μM																99.37%
Lacto-N-fucopentaose I		CDK2/cyclinE																							99.92%
Avotaciclib	CDK1																								99.72%
Romaciclib hydrochloride								CDK8/CycC, IC₅₀: 4.4 nM	CDK9/cycT, IC₅₀: 1070 nM						CDK19/CycC, IC₅₀: 10.4 nM										99.98%
NU6102	Cdk1/cyclin B, IC₅₀: 9.5 nM	CDK2/cyclin A3, IC₅₀: 5.4 nM		CDK4, IC₅₀: 1.6 μM																					99.23%
Abemaciclib metabolite M2				CDK4, IC₅₀: 1.2 nM		CDK6, IC₅₀: 1.3 nM																			99.75%
Samuraciclib	CDK1, IC₅₀: 1.8 μM	CDK2/cycE1, IC₅₀: 578 nM		CDK4, IC₅₀: 49 μM	CDK5, IC₅₀: 9.4 μM	CDK6, IC₅₀: 34 μM	CDK7/CycH/MAT1, IC₅₀: 41 nM		CDK9, IC₅₀: 1.2 μM																99.55%
PHA-767491	CDK1, IC₅₀: 250 nM	CDK2, IC₅₀: 240 nM			CDK5, IC₅₀: 460 nM				CDK9, IC₅₀: 34 nM																99.97%
DS96432529								CDK8																	99.93%
(±)-Enitociclib									CDK9																99.23%
JSH-150	Cdk1/cyclin B, IC₅₀: 1.34 μM	cdk2/cyclin A, IC₅₀: 2.86 μM			Cdk5/p25, IC₅₀: 4.64 μM		CDK7/Cyclin H/MNAT1, IC₅₀: 1.72 μM		CDK9/cyclinT1, IC₅₀: 1 nM				CDK14/Cyclin Y, IC₅₀: 1.68 μM	CDK16/Cyclin Y, IC₅₀: 292 nM											98.36%
Purvalanol B	cdc2/cyclin B, IC₅₀: 6 nM	cdk2/cyclin A, IC₅₀: 6 nM CDK2/cyclinE, IC₅₀: 9 nM			CDK5/p35, IC₅₀: 6 nM
BRD6989								CDK8, IC₅₀: ~200 nM recombinant CDK8, IC₅₀: ~0.5 μM							recombinant CDK19, IC₅₀: >30 μM										99.54%
ML167			CDK3, IC₅₀: ＞10000 nM														CLK4, IC₅₀: 136 nM CLK1, IC₅₀: 1522 nM CLK2, IC₅₀: 1648 nM								98.62%
CDK5 inhibitor 20-223		CDK2, IC₅₀: 6.0 nM			CDK5, IC₅₀: 8.8 nM																				99.62%
KI-CDK9d-32									CDK9, DC₅₀: 0.89 nM																99.03%
CPD-39				CDK4																					98.06%
YX-2-107						CDK6, IC₅₀: 4.4 nM																			98.60%
CDK2 degrader 6		CDK2, DC₅₀: 46.5 nM																							99.81%
Flavone	CDK1/cyclinB1																								99.85%
Abemaciclib metabolite M18 hydrochloride				CDK4		CDK6																			98.18%
THZ2	CDK1, IC₅₀: 96.9 nM	CDK2, IC₅₀: 222 nM			CDK5, IC₅₀: 134 nM		CDK7, IC₅₀: 13.9 nM	CDK8, IC₅₀: 6830 nM	CDK9, IC₅₀: 194 nM																99.03%
Epmedin C		CDK2/cyclinE																							99.47%
Leucettine L41																	CLK1, IC₅₀: 71 nM CLK4, IC₅₀: 64 nM								98.98%
MC180295	CDK1-Cyclin B, IC₅₀: 138 nM	cdk2-cyclin A, IC₅₀: 233 nM cdk2-cyclin E, IC₅₀: 367 nM	CDK3-Cyclin E, IC₅₀: 399 nM	CDK4-Cyclin D, IC₅₀: 112 nM	cdk5-p35, IC₅₀: 159 nM cdk5-p25, IC₅₀: 186 nM	cdk6-cyclin D3, IC₅₀: 712 nM	CDK7-CycH/MAT1, IC₅₀: 555 nM		CDK9- Cyclin T1, IC₅₀: 5 nM																98.07%
CDK12-IN-2		CDK2, IC₅₀: >100 μM					CDK7, IC₅₀: >10 μM CDK7, IC₅₀: >10 μM		CDK9, IC₅₀: 16 μM		CDK12, IC₅₀: 52 nM														99.36%
KH-CB19																	CLK1, IC₅₀: 19.7 nM CLK3, IC₅₀: 530 nM								99.31%
CDK5-IN-3		CDK2/CycA, IC₅₀: 18 nM			Cdk5/p25, IC₅₀: 0.6 nM																				99.49%
K00546	Cdk1/cyclin B, IC₅₀: 0.6 nM	cdk2/cyclin A, IC₅₀: 0.5 nM															CLK1, IC₅₀: 8.9 nM CLK3, IC₅₀: 29.2 nM								99.48%
CLK1-IN-1																	CLK1, IC₅₀: 2 nM								98.55%
FN-1501		cdk2/cyclin A, IC₅₀: 2.47 nM		Cdk4/cyclin D1, IC₅₀: 0.85 nM		CDK6/cyclinD1, IC₅₀: 1.96 nM																			98.72%
Bisindolylmaleimide X hydrochloride		CDK2, IC₅₀: 200 nM																							98.90%
Lerociclib dihydrochloride	CDK1/cyclinB1, IC₅₀: 2.4 μM	cdk2/cyclin A, IC₅₀: 1.5 μM CDK2/cyclinE, IC₅₀: 3.6 μM		Cdk4/cyclin D1, IC₅₀: 1 nM	CDK5/p35, IC₅₀: 832 nM Cdk5/p25, IC₅₀: 1.2 μM	cdk6/cyclin D3, IC₅₀: 2 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2.4 μM		CDK9/Cyclin T, IC₅₀: 28 nM																98.51%
Riviciclib hydrochloride	CDK1-Cyclin B, IC₅₀: 0.079 μM	cdk2-cyclin A, IC₅₀: 0.224 μM cdk2-cyclin E, IC₅₀: 2.500 μM		cdk4-cyclin D1, IC₅₀: 0.063 μM		cdk6-cyclin D3, IC₅₀: 0.396 μM			CDK9- Cyclin T1, IC₅₀: 0.020 μM CDK9-cyclin H, IC₅₀: 2.900 μM																99.08%
BS-181 hydrochloride	CDK1/cycB, IC₅₀: 8.1 μM	CDK2/Cyc E, IC₅₀: 0.88 μM		CDK4/Cyc D1, IC₅₀: 33 μM	CDK5/p35NCK, IC₅₀: 3 μM	CDK6/cycD1, IC₅₀: 47 μM	CDK7/CycH/MAT1, IC₅₀: 0.021 μM		CDK9/cycT, IC₅₀: 4.2 μM																99.93%
GW8510		CDK2			CDK5																				99.04%
CC-671																	CLK2, IC₅₀: 0.006 μM								99.06%
CKI-7 free base																Cdc7									99.31%
TC11	CDK1																								99.55%
Abemaciclib metabolite M20				CDK4		CDK6
PROTAC CDK4/6 degrader 1				CDK4, DC₅₀: 10.5 nM		CDK6, DC₅₀: 2.5 nM																			98.88%
β-catenin-IN-3				Cdk4/cyclin D1
CP-10						CDK6, DC₅₀: 2.1 nM																			98.41%
Lerociclib	CDK1/cyclinB1, IC₅₀: 2.4 μM	cdk2/cyclin A, IC₅₀: 1.5 μM CDK2/cyclinE, IC₅₀: 3.6 μM		Cdk4/cyclin D1, IC₅₀: 1 nM	CDK5/p35, IC₅₀: 0.832 μM Cdk5/p25, IC₅₀: 1.2 μM	cdk6/cyclin D3, IC₅₀: 2 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2.4 μM		CDK9/Cyclin T, IC₅₀: 28 nM																98.35%
Tabersonine				CDK4																					98.13%
CDK2-IN-30		CDK2, IC₅₀: ≤ 20 nM																							98.40%
LL-K8-22								CDK8, DC₅₀: 2.52 μM																	99.06%
XY028-133				CDK4		CDK6																			99.07%
Ipivivint		CDK2, EC₅₀: 1 nM	CDK3, EC₅₀: 7 nM																						99.95%
CDK2 degrader 7	CDK1, DC₅₀: 2130 nM	CDK2, DC₅₀: 13 nM (MKN1cells) CDK2, DC₅₀: 17 nM (TOV21G cells)																							99.51%
SNX7886								CDK8							CDK19										99.71%
JH-XI-10-02								CDK8, IC₅₀: 159 nM																	99.73%
PROTAC CDK9 Degrader-1									CDK9																99.55%
AS2863619 free base								CDK8, IC₅₀: 0.61 nM							CDK19, IC₅₀: 4.28 nM										99.87%
YK-2168	CDK1, IC₅₀: 427.7 nM	CDK2, IC₅₀: 266.9 nM							CDK9, IC₅₀: 5.9 nM																98.05%
Samuraciclib hydrochloride dihydrate	CDK1, IC₅₀: 1.8 μM	CDK2, IC₅₀: 578 nM		CDK4, IC₅₀: 49 μM	CDK5, IC₅₀: 9.4 μM	CDK6, IC₅₀: 31 μM	CDK7, IC₅₀: 41 nM		CDK9, IC₅₀: 1.2 μM																99.90%
CDK2 degrader 3		CDK2																							99.91%
JH-XVI-178								CDK8, IC₅₀: 1 nM							CDK19, IC₅₀: 2 nM										98.87%
LY2857785							CDK7, IC₅₀: 0.246 μM	CDK8, IC₅₀: 0.016 μM	CDK9, IC₅₀: 0.011 μM																99.21%
LDC4297							CDK7, IC₅₀: 0.13 nM																		99.74%
CDK9 inhibitor HH1									CDK9																99.69%
TMX-3013	CDK1, IC₅₀: 0.9 nM	CDK2, IC₅₀: <0.5 nM		CDK4, IC₅₀: 24.5 nM	CDK5, IC₅₀: 0.5 nM	CDK6, IC₅₀: 15.6 nM																			98.02%
AZD5597	CDK1, IC₅₀: 2 nM	CDK2, IC₅₀: 2 nM																							98.09%
Ryuvidine				CDK4, IC₅₀: 6.0 μM																					99.23%
CDK9-IN-1									CDK9/CycT1, IC₅₀: 39 nM																98.52%
Longdaysin							CDK7, IC₅₀: 29 μM																		99.83%
YKL-5-124 TFA		CDK2, IC₅₀: 1300 nM					CDK7, IC₅₀: 53.5 nM CDK7/Mat1/CycH, IC₅₀: 9.7 nM		CDK9, IC₅₀: 3020 nM																99.74%
AMG 925	CDK1, IC₅₀: 1.9 μM	CDK2, IC₅₀: 375 nM		CDK4, IC₅₀: 3 nM		CDK6, IC₅₀: 8 nM																			99.02%
PROTAC CDK12/13 Degrader-1 TFA											CDK12, DC₅₀: 2.2 nM	CDK13, DC₅₀: 2.1 nM													99.12%
Q901							CDK7, IC₅₀: 10 nM																		98.38%
Senexin C								CDK8/CycC, IC₅₀: 3.6 nM CDK8/CycC, Kd: 1.4 nM							CDK19/CycC, Kd: 2.9 nM										99.19%
(E/Z)-Zotiraciclib hydrochloride		CDK2																							99.90%
Daphnoretin		CDK2/cyclinE																							99.83%
Olomoucine		cdk2-cyclin A, IC₅₀: 7 μM cdk2-cyclin E, IC₅₀: 7 μM			cdk5-p35, IC₅₀: 25 μM																				99.88%
CDK-TCIP1									CDK9																98.86%
BSJ-5-63							CDK7		CDK9		CDK12														99.97%
Desmethylglycitein	CDK1	CDK2																							99.99%
Abemaciclib metabolite M18				CDK4		CDK6																			98.01%
LL-K12-18											CDK12/Cyclin K, IC₅₀: 283.9 nM														98.42%
CDK12-IN-3											CDK12, IC₅₀: 491 nM														99.86%
AT7519 Hydrochloride	Cdk1/cyclin B, IC₅₀: 210 nM	cdk2/cyclin A, IC₅₀: 47 nM		Cdk4/cyclin D1, IC₅₀: 100 nM	CDK5/p35, IC₅₀: 13 nM	cdk6/cyclin D3, IC₅₀: 170 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2400 nM		CDK9/Cyclin T, IC₅₀: 10 nM																99.16%
(S)-Roscovitine	CDK1, IC₅₀: ≤1 μM	CDK2, IC₅₀: ≤1 μM			CDK5, IC₅₀: ≤1 μM		CDK7, IC₅₀: ≤1 μM		CDK9, IC₅₀: ≤1 μM																99.15%
(-)-Enitociclib									CDK9																99.85%
CDK1-IN-1	CDK1/cycB, IC₅₀: 161.2 nM																								99.33%
Halcinonide						Cdk6/cyclin D2																			98.29%
Manzamine A hydrochloride					CDK5, IC₅₀: 1.5 μM																				99.66%
TMX-2172		CDK2, IC₅₀: 6.5 nM			CDK5, IC₅₀: 6.8 nM																				99.38%
CDK4 degrader 1				CDK4																					99.83%
CDK2 degrader 5		CDK2																							99.17%
CPD-10				CDK4																					98.59%
ECI830		CDK2																							98.01%
Palbociclib-d₈				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM																			99.84%
BSJ-01-175											CDK12	CDK13													99.88%
CDK9-IN-13	CDK1, IC₅₀: 0.14 μM	CDK2, IC₅₀: 0.72 μM					CDK7, IC₅₀: 0.40 μM		CDK9, IC₅₀: <3 nM		CDK12, IC₅₀: 0.055 μM														99.94%
LDC4297 hydrochloride							CDK7, IC₅₀: 0.13 nM																		98.23%
CDK2/4/6-IN-2		CDK2		CDK4		CDK6																			98.20%
S6K1-IN-1																	CLK1								99.71%
MU1210																	CLK1, IC₅₀: 8 nM CLK2, IC₅₀: 20 nM CLK4, IC₅₀: 12 nM								99.50%
CDK8-IN-13								CDK8, IC₅₀: 51.9 nM																	99.14%
ZLC491											CDK12	CDK13													98.51%
CDD-2807																	CLK4, IC₅₀: 85 nM CLK2, IC₅₀: 101 nM CLK1, IC₅₀: 116 nM								99.52%
RGB-286638 free base	cyclin B1-CDK1, IC₅₀: 2 nM	cyclin E-CDK2, IC₅₀: 3 nM	cyclin E-CDK3, IC₅₀: 5 nM	cyclin D1-CDK4, IC₅₀: 4 nM	p35-CDK5, IC₅₀: 5 nM	cyclin D3-CDK6, IC₅₀: 55 nM	cyclin H-CDK7, IC₅₀: 44 nM		T1-CDK9, IC₅₀: 1 nM																98.09%
Butyrolactone I	CDK1																								99.80%
Zotiraciclib		CDK2, IC₅₀: 56 nM																							99.88%
EHT 5372																	CLK1, IC₅₀: 22.8 nM CLK2, IC₅₀: 88.8 nM CLK4, IC₅₀: 59.0 nM								98.12%
CDDD11-8									CDK9, Ki: 8 nM																99.62%
CDK8 ligand 1								CDK8							CDK19										99.88%
NU6027	CDK1, Ki: 2.5 μM	CDK2, Ki: 1.3 μM																							98.01%
CGP-74514	CDK1/cyclinB1, IC₅₀: 25 nM																								98.02%
Aristolochic acid D		CDK2, IC₅₀: 25 μM																							99.74%
CDK12-IN-6		CDK2/cyclinE, IC₅₀: >20 μM							CDK9/cyclinT1, IC₅₀: >20 μM		CDK12, IC₅₀: 1.19 μM														99.15%
CDK-IN-2									CDK9/cyclinT1, IC₅₀: 8 nM																99.27%
CDK4/6-IN-15		CDK2, IC₅₀: 3.335 μM		CDK4, IC₅₀: 3 nM		CDK6, IC₅₀: 0.279 μM																			99.32%
CDK7-IN-4							CDK7																		98.87%
CLK1-IN-3																	CLK1, IC₅₀: 5 nM CLK2, IC₅₀: 42 nM CLK4, IC₅₀: 108 nM								98.54%
TMX-2039	CDK1, IC₅₀: 2.6 nM	CDK2, IC₅₀: 1.0 nM		CDK4, IC₅₀: 52.1 nM	CDK5, IC₅₀: 0.5 nM	CDK6, IC₅₀: 35 nM	CDK7, IC₅₀: 32.5 nM		CDK9, IC₅₀: 25 nM																99.42%
LY3177833																Cdc7, IC₅₀: 3.3 nM									99.56%
Atuveciclib Racemate									CDK9																98.48%
Ribociclib succinate hydrate				CDK4, IC₅₀: 10 nM		CDK6, IC₅₀: 39 nM																			99.94%
NU6140	CDK1-Cyclin B, IC₅₀: 6.6 μM	cdk2-cyclin A, IC₅₀: 0.41 μM		CDK4-Cyclin D, IC₅₀: 5.5 μM	cdk5-p25, IC₅₀: 15 μM		cdk7-cyclin H, IC₅₀: 3.9 μM																		99.53%
Samuraciclib hydrochloride hydrate	CDK1, IC₅₀: 1.8 μM	CDK2/cycE1, IC₅₀: 578 nM		CDK4, IC₅₀: 49 μM	CDK5, IC₅₀: 9.4 μM	CDK6, IC₅₀: 34 μM	CDK7/CycH/MAT1, IC₅₀: 41 nM		CDK9, IC₅₀: 1.2 μM																99.88%
TP-1287									CDK9
PROTAC CDK12/13 Degrader-1											CDK12, DC₅₀: 2.2 nM	CDK13, DC₅₀: 2.1 nM													98.01%
FIT-039									CDK9/cyclinT1, IC₅₀: 5.8 μM																99.56%
PPA-037 TFA											CDK12/Cyclin K														99.42%
7BIO					CDK5																				99.20%
CDK4-IN-3				CDK4, IC₅₀: 25 nM																					98.07%
SRX3177				CDK4, IC₅₀: < 2.5 nM		CDK6, IC₅₀: 3.3 nM																			99.33%
CDK8-IN-11								CDK8, IC₅₀: 46 nM																	98.18%
Isosilybin B		CDK2		CDK4																					99.32%
DB1113				CDK4						CDK11B															99.86%
RSS0680	CDK1	CDK2		CDK4		CDK6								CDK16/Cyclin Y											98.03%
CDK2-IN-3		CDK2, IC₅₀: 60 nM
CDK2-IN-31		CDK2																							98.22%
CDK12-IN-E9		cdk2/cyclin A, IC₅₀: 932 nM					CDK7/Cyclin H/MNAT1, IC₅₀: 1210 nM		CDK9/cyclinT1, IC₅₀: 23.9 nM																99.71%
DD-03-156																					CDK17				99.90%
(E/Z)-Zotiraciclib citrate		CDK2																							99.83%
CKI-7																Cdc7									99.97%
CDK2 degrader 4		CDK2																							99.71%
HEMTAC CDK4/6 degrader 1				CDK4		CDK6																			98.18%
GSK-3 inhibitor 3		CDK2, IC₅₀: 0.22 μM			CDK5, IC₅₀: 1.3 μM																				99.10%
Cyproheptadine (hydrochloride sesquihydrate)	CDK1	CDK2	CDK3																						99.74%
SB1-G-187					CDK5								CDK14/Cyclin Y												98.70%
Vanicoside B			CDK3																						99.82%
BS-194	CDK1, IC₅₀: 30 nM	CDK2, IC₅₀: 3 nM			CDK5, IC₅₀: 30 nM		CDK7, IC₅₀: 250 nM		CDK9, IC₅₀: 90 nM																99.13%
Cdk5i peptide					Cdk5/p25, Kd: 0.17 μM CDK5, Kd: 15.72 μM																				98.93%
CDK9-IN-2									CDK9, IC₅₀: 5 nM (H929 multiple myeloma cell line)																98.72%
CDK9-IN-8									CDK9, IC₅₀: 12 nM																99.16%
CDK4/6-IN-2				CDK4, IC₅₀: 2.7 nM		CDK6, IC₅₀: 16 nM																			99.67%
Voruciclib hydrochloride	CDK1/cycB, Ki: 5.4 nM CDK1/cyc A, Ki: 9.1 nM			CDK4/Cyc D1, Ki: 3.96 nM		CDK6/cycD1, Ki: 2.92 nM			CDK9/CycT1, Ki: 1.68 nM CDK9/cyc T2, Ki: 0.626 nM																99.26%
Avotaciclib trihydrochloride	CDK1																								99.60%
PROTAC CDK9 degrader-9									CDK9																99.25%
HTH-01-091							CDK7, IC₅₀: 1230 nM																		99.81%
CDK8/19-IN-1								CDK8/CycC, IC₅₀: 0.46 nM	CDK9, IC₅₀: 270 nM						CDK19/CycC, IC₅₀: 0.99 nM										98.08%
CDK9-IN-11									CDK9
dCDK9-202									CDK9, DC₅₀: 3.5 nM																99.25%
YKL-1-116							CDK7																		98.67%
Cdk1/2 Inhibitor III	Cdk1/cyclin B, IC₅₀: 0.6 nM	CDK2/cyclinA, IC₅₀: 0.5 nM																							99.69%
BGG463		CDK2																							98.0%
5-Iodo-indirubin-3'-monoxime	Cdk1/cyclin B, IC₅₀: 25 nM				Cdk5/p25, IC₅₀: 20 nM																				98.12%
ABC1183									CDK9- Cyclin T1, IC₅₀: 321 nM																99.62%
CDK7 ligand 2							CDK7																		99.92%
CDK9-IN-12									CDK9/cyclinT1, IC₅₀: 5.41 nM																99.65%
Ca2+ channel agonist 1		CDK2, EC₅₀: 3.34 μM																							98.87%
PNU-292137	CDK1/cyclinB, IC₅₀: 270 nM	CDK2/cyclinA, IC₅₀: 37 nM CDK2/cyclin E, IC₅₀: 92 nM		CDK4/cyclinD1, IC₅₀: >10000 nM	Cdk5/p25, IC₅₀: 114 nM																				99.95%
CDK9-IN-7				CDK4/cyclin D, IC₅₀: 148 nM		CDK6/cyclinD, IC₅₀: 145 nM			CDK9/cyclinT1, IC₅₀: 11 nM																98.05%
CAN508	Cdk1/cyclin B, IC₅₀: 44 μM	CDK2/cyclinE, IC₅₀: 20 μM cdk2/cyclin A, IC₅₀: 69 μM		Cdk4/cyclin D1, IC₅₀: 13.5 μM			CDK7/cyclin H, IC₅₀: 26 μM		CDK9/cyclinT1, IC₅₀: 0.35 μM																99.71%
BI-1622										CDK11B															98.02%
CDK2-IN-22		CDK2, IC₅₀: 64.42 nM																							98.64%
Avotaciclib hydrochloride	CDK1																								99.75%
(S)-JWZ-5-13							CDK7, IC₅₀: 21.1 nM																		99.62%
Inixaciclib		CDK2		CDK4		CDK6																			99.93%
HS-243																	CLK4, IC₅₀: 662 nM								99.95%
PROTAC CDK9 degrader-2									CDK9, IC₅₀: 17 μM (MCF-7 cells)																99.22%
NSC 625987				CDK4/D1, IC₅₀: 0.2 μM																					98.01%
CDK5-IN-1					CDK5, IC₅₀: < 10 nM																				98.47%
SHR5428	CDK1, IC₅₀: >100 μM	CDK2, IC₅₀: 8.99 μM		CDK4, IC₅₀: 3.87 μM		CDK6, IC₅₀: 5.89 μM	CDK7, IC₅₀: 0.005 μM		CDK9, IC₅₀: 8.30 μM		CDK12, IC₅₀: 1.11 μM														99.80%
AG-012986	Cdk1/cyclin B, Ki: 44 nM	cdk2/cyclin A, Ki: 94 nM		CDK4, Ki: 9.2 nM	CDK5/p35, IC₅₀: 22 nM				CDK9/Cyclin T, IC₅₀: 4 nM																99.78%
CDK1-IN-2	CDK1, IC₅₀: 5.8 μM																								98.89%
DDO-6079																CDC37									98.92%
CGP-82996	CDK1/cyclinB, IC₅₀: >100 μM	CDK2/cyclinA, IC₅₀: >50 μM CDK2/cyclin E, IC₅₀: >50 μM		Cdk4/cyclin D1, IC₅₀: 1.5 μM CDK4/cyclin D2, IC₅₀: >50 μM	CDK5/p35, IC₅₀: 25 μM	CDK6/cyclinD1, IC₅₀: 5.6 μM Cdk6/cyclin D2, IC₅₀: >50 μM																			98.12%
Damulin B				CDK4		CDK6
SEL120-34A								CDK8/CycC, IC₅₀: 4.4 nM	CDK9/cycT, IC₅₀: 1070 nM						CDK19/CycC, IC₅₀: 10.4 nM										99.49%
KH-CB20																	CLK1, IC₅₀: 16.5 nM CLK3, IC₅₀: 488 nM								99.80%
Casein Kinase inhibitor A86							CDK7, Kd: 0.31 nM		CDK9, Kd: 5.4 nM																99.26%
(R)-CDK2 degrader 6		CDK2, DC₅₀: 27 nM																							99.55%
Abemaciclib metabolite M20-d₈				CDK4		CDK6																			99.26%
NU2058	CDK1, IC₅₀: 26 μM	CDK2, IC₅₀: 17 μM CDK2, Ki: 12 μM																							99.66%
ON-013100				Cdk4/cyclin D1																					99.66%
AT7519 TFA	Cdk1/cyclin B, IC₅₀: 210 nM	cdk2/cyclin A, IC₅₀: 47 nM		Cdk4/cyclin D1, IC₅₀: 100 nM	CDK5/p35, IC₅₀: 13 nM	cdk6/cyclin D3, IC₅₀: 170 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2400 nM		CDK9/Cyclin T, IC₅₀: 10 nM																99.75%
CDK9/EZH2-IN-1									CDK9, IC₅₀: 83.9 nM																99.08%
CDK4/6-IN-12				CDK4, IC₅₀: 592.3 nM		CDK6, IC₅₀: 3090 nM																			99.76%
CDK1-IN-6	CDK1																								99.96%
CDK12-IN-5		CDK2/cyclinE, IC₅₀: 173 μM							CDK9/cyclinT1, IC₅₀: 127 μM		CDK12, IC₅₀: 23.9 nM														98.03%
Fascaplysin				CDK4
Tambiciclib dimaleate	CDK1/cyclinB, IC₅₀: 5410 nM	CDK2/cyclinA, IC₅₀: 6850 nM	CDK3/cyclin E1, IC₅₀: >10,000 nM		Cdk5/p25, IC₅₀: 6950 nM		CDK7/Cyclin H/MNAT1, IC₅₀: 3700 nM	CDK8/cyclin C, IC₅₀: >10,000 nM	CDK9/cyclinT1, IC₅₀: 1 nM	CDK11, IC₅₀: >10,000 nM			CDK14/Cyclin Y, IC₅₀: 2710 nM	CDK16/Cyclin Y, IC₅₀: 195 nM											99.53%
CK7		CDK2							CDK9																99.72%
CLK1/2-IN-1																	CLK1, IC₅₀: 16 nM CLK2, IC₅₀: 45 nM								99.87%
YX0798									CDK9, Kd: 0.28 nM																98.90%
CDK4/6-IN-9						CDK6/cyclinD1, IC₅₀: 905 nM																			99.46%
NecroIr1				CDK4																					98.53%
NVP-LCQ195	Cdk1/cyclin B, IC₅₀: 2 nM	cdk2/cyclin A, IC₅₀: 2 nM CDK2/cyclinE, IC₅₀: 5 nM	CDK3/Cyclin E, IC₅₀: 42 nM		Cdk5/p25, IC₅₀: 1 nM CDK5/p35, IC₅₀: 1 nM	cdk6/cyclin D3, IC₅₀: 187 nM	CDK7/Cyclin H/MAT1, IC₅₀: 3564 nM		CDK9/cyclinT1, IC₅₀: 15 nM																98.81%
LDC3140							CDK7, IC₅₀: <5 nM																		99.81%
LA-CB1				CDK4		CDK6																			98.20%
CDK6/PIM1-IN-1 hydrochloride				CDK4, IC₅₀: 3.6 nM		CDK6, IC₅₀: 39 nM																			99.38%
DB0614						CDK6								CDK16/Cyclin Y
(R)-DRF053 dihydrochloride	CDK1/cyclinB1, IC₅₀: 220 nM				Cdk5/p25, IC₅₀: 80 nM																				99.30%
Rafutrombopag				CDK4		CDK6
BS-181	CDK1/cycB, IC₅₀: 8.1 μM	CDK2/Cyc E, IC₅₀: 0.88 μM		CDK4/Cyc D1, IC₅₀: 33 μM	CDK5/p35NCK, IC₅₀: 3 μM	CDK6/cycD1, IC₅₀: 47 μM	CDK7/CycH/MAT1, IC₅₀: 0.021 μM		CDK9/cycT, IC₅₀: 4.2 μM																98.10%
PROTAC CDK2/4 Degrader-1		CDK2, DC₅₀: ≤ 10 nM		CDK4, DC₅₀: ≤ 10 nM
Cardanol monoene		cdk2/cyclin A																							99.51%
YJ9069											CDK12	CDK13
HQY1428											CDK12														99.65%
(E/Z)-BIO-acetoxime	CDK1/cyclinB, IC₅₀: 63 μM	CDK2/cyclinA, IC₅₀: 4.3 μM			Cdk5/p25, IC₅₀: 2.4 μM																				99.9%
CDK1/Cyc B-IN-1	CDK1-Cyclin B, IC₅₀: 97 nM																								98.47%
NSC693868	Cdk1/cyclin B, IC₅₀: 600 nM				Cdk5/p25, IC₅₀: 400 nM																				99.0%
THZ1-R							CDK7, IC₅₀: 146 nM																		98.06%
INK4C-IN-2				CDK4		CDK6																			98.10%
ZDLD20				CDK4/CycD3, IC₅₀: 6.51 μM																					99.84%
NecroIr2				CDK4																					98.02%
CDK2-IN-40		CDK2/cyclinE, IC₅₀: 10 nM																							99.80%
GSK-3 inhibitor 4		CDK2, IC₅₀: 0.47 μM			CDK5, IC₅₀: 0.68 μM																				99.02%
CDK12/13-IN-3											CDK12, IC₅₀: 107.4 nM	CDK13, IC₅₀: 79.4 nM													99.14%
Aurora-A ligand 1		CDK2		CDK4		CDK6																			98.75%
CDK9-IN-14									CDK9, IC₅₀: 6.92 nM																99.91%
P18IN003				CDK4		CDK6																			99.49%
CDK8-IN-1								CDK8, IC₅₀: 3 nM																	98.62%
CDK7-IN-1							CDK7, IC₅₀: 100 nM																		98.91%
GDC-4198		CDK2		CDK4
(S)-LY3177833 hydrate																Cdc7
IV-361		CDK2, Ki: ≥1000 nM					CDK7, Ki: ≤50 nM																		99.60%
LY3177833 monhydrate																Cdc7, IC₅₀: 3.3 nM									99.76%
Cimpuciclib tosylate				CDK4, IC₅₀: 0.49 nM		CDK6, IC₅₀: 9.56 nM																			99.65%
PROTAC CDK9 ligand-1									CDK9																99.75%
CDK4/6-IN-18				CDK4		CDK6																			98.9%
KY19334	CDK1
DDO-6600				CDK4																					99.2%
PT-262		CDK2																							99.21%
DYRK2-IN-2																	CLK1, IC₅₀: 1128 nM CLK2, IC₅₀: 4290 nM CLK3, IC₅₀: 6496 nM CLK4, IC₅₀: 536.9 nM
PPA-037											CDK12/Cyclin K
Bohemine		CDK2/cyclinE, IC₅₀: 4.6 μM cdk2/cyclin A, IC₅₀: 83 μM							CDK9/cyclinT1, IC₅₀: 2.7 μM																98.93%
Multi-target kinase inhibitor 2		CDK2, IC₅₀: 204 nM																							99.82%
Akt1&PKA-IN-1		CDK2, IC₅₀: 9.8 μM
CDK8-IN-12								CDK8, Ki: 14 nM																	99.74%
RGB-286147	CDK1/cyclinB, IC₅₀: 48 nM	CDK2/E, IC₅₀: 15 nM		CDK4/D1, IC₅₀: 839 nM		cdk6/cyclin D3, IC₅₀: 232 nM																			98.60%
CDK6/PIM1-IN-1	CDK1/cyclinB, IC₅₀: >10 μM	CDK2/cyclinA, IC₅₀: 2.274 μM	CDK3/Cyclin E, IC₅₀: >10 μM	Cdk4/cyclin D1, IC₅₀: 3.6 nM	Cdk5/p25, IC₅₀: >10 μM	CDK6/cyclinD1, IC₅₀: 39 nM	CDK7/Cyclin H/MNAT1, IC₅₀: 393 nM		CDK9/cyclinT1, IC₅₀: 440 nM		CDK12/Cyclin K, IC₅₀: >10 μM	CDK13/Cyclin K, IC₅₀: >10 μM
JH-VIII-49								CDK8, IC₅₀: 16 nM
PROTAC CDK6 Degrader 1						CDK6, DC₅₀: 0.037 μM
P162-0948								CDK8, IC₅₀: 50.4 nM
AMG 925 (HCl)	CDK1, IC₅₀: 1.9 μM	CDK2, IC₅₀: 375 nM		CDK4, IC₅₀: 3 nM		CDK6, IC₅₀: 8 nM
DYRK2-IN-2 hydrochloride																	CLK1, IC₅₀: 1128 nM CLK2, IC₅₀: 4290 nM CLK3, IC₅₀: 6496 nM CLK4, IC₅₀: 536.9 nM
Akt1&PKA-IN-2		CDK2^a, IC₅₀: 0.69 μM
Sinigrin hydrate				CDK4		CDK6																			99.92%
PNU112455A hydrochloride		CDK2, Km: 3.6 μM			CDK5, Km: 3.2 μM																				99.56%
cis-Trismethoxy resveratrol	CDK1																								99.87%
Manzamine A					CDK5, IC₅₀: 1.5 μM																				98.2%
XYD049		CDK2																							99.46%
AO-365/43472821																	CLK1, IC₅₀: 0.08 μM								99.94%
CDK7-IN-28		cdk2/cyclin A, IC₅₀: 6224 nM					CDK7/Cyclin H/MNAT1, IC₅₀: ＜5 nM					CDK13/Cyclin K, IC₅₀: 152 nM
PROTAC FLT3/CDKs degrader-1		CDK2, DC₅₀: 18.73 nM
CDK12-IN-8											CDK12														99.52%
(S)-JNJ-3738							CDK7
KWZY-11						CDK6, IC₅₀: 13.3 nM
CDK9-IN-10									CDK9																98.09%
TMX-2138	CDK1/cyclinB, IC₅₀: 8.7 nM	CDK2/cyclinA, IC₅₀: 10.9 nM		CDK4/cyclinD1, IC₅₀: 901 nM	Cdk5/p25, IC₅₀: 7.0 nM	CDK6/cyclinD1, IC₅₀: 465 nM	CDK7/cyclin H, IC₅₀: 286 nM		CDK9/cyclinT1, IC₅₀: 25.7 nM
PROTAC CDK2/4/6 Degrader-2		CDK2	CDK3	CDK4		CDK6
JA397													CDK14/Cyclin Y, EC₅₀: 27.1 nM	CDK16/Cyclin Y, EC₅₀: 39.0 nM
PROTAC D16-M1P2	CDK1
GW297361	yeast Cdk1, IC₅₀: 20 nM human CDK1, IC₅₀: 30 nM	human CDK2, IC₅₀: 1.9 nM		human CDK4, IC₅₀: 300 nM					human CDK9, IC₅₀: 10 nM									yeast Pho85, IC₅₀: 400 nM							98.13%
Olomoucine II	Cdk1/cyclin B, IC₅₀: 7.6 μM	CDK2/cyclinE, IC₅₀: 0.1 μM		CDK4/cyclinD1, IC₅₀: 19.8 μM			CDK7/cyclin H, IC₅₀: 0.45 μM		CDK9/cycT, IC₅₀: 0.06 μM
(R)-(+)-O-Demethylbuchenavianine	CDK1, IC₅₀: 1.1 μM				CDK5, IC₅₀: 0.95 μM																				98.67%
CA224		cdk2-cyclin A, IC₅₀: 521 μM		cdk4-cyclin D1, IC₅₀: 6.2 μM																					99.94%
Palbociclib dihydrochloride				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM
Palbociclib orotate				Cdk4/cyclin D3, IC₅₀: 9 nM Cdk4/cyclin D1, IC₅₀: 11 nM		Cdk6/cyclin D2, IC₅₀: 16 nM
CDK1-IN-5	CDK1, IC₅₀: 42.19 nM	CDK2, IC₅₀: 188.71 nM			CDK5, IC₅₀: 354.15 nM
Cimpuciclib				CDK4, IC₅₀: 0.49 nM		CDK6, IC₅₀: 9.56 nM
DN1679											CDK12, DC₅₀: 8.8 nM	CDK13, DC₅₀: 9.8 nM
CDK1-IN-3	CDK1, IC₅₀: 36.8 nM	CDK2, IC₅₀: 305.17 nM			CDK5, IC₅₀: 369.37 nM
HDAC1/2 and CDK2-IN-1		CDK2, IC₅₀: 0.80 nM
XL495	CDK1
OTS964										CDK11B, Kd: 40 nM
ZLMT-12		CDK2, IC₅₀: 0.011 μM							CDK9, IC₅₀: 0.002 μM
CDK7-IN-2 hydrochloride hydrate							CDK7
BS-181 dihydrochloride		CDK2, IC₅₀: 880 nM			CDK5, IC₅₀: 3000 nM		CDK7, IC₅₀: 21 nM		CDK9, IC₅₀: 4200 nM
CDK4/6-IN-3	CDK1, Ki: 110 nM			CDK4, Ki: 0.3 nM		CDK6, Ki: 2.2 nM
FN-1501-propionic acid		CDK2							CDK9
CDK9-IN-9		CDK2, IC₅₀: 155 nM							CDK9, IC₅₀: 1.8 nM
CDK7-IN-11							CDK7, IC₅₀: 4.2 nM
Riviciclib	CDK1-Cyclin B, IC₅₀: 0.079 μM	cdk2-cyclin A, IC₅₀: 0.224 μM cdk2-cyclin E, IC₅₀: 2.540 μM		cdk4-cyclin D1, IC₅₀: 0.063 μM		cdk6-cyclin D3, IC₅₀: 0.396 μM			CDK9- Cyclin T1, IC₅₀: 0.020 μM CDK9-cyclin H, IC₅₀: 2.900 μM
CDK6/9-IN-1						CDK6, IC₅₀: 40.5 nM			CDK9, IC₅₀: 39.5 nM
Senexin A hydrochloride								CDK8, IC₅₀: 280 nM CDK8, Kd: 0.83 μM							CDK19, Kd: 0.31 μM
Amantadine sulfate		CDK2
CDK7-IN-30	CDK1, IC₅₀: >10000.00 nM	CDK2, IC₅₀: 734.55 nM	CDK3, IC₅₀: 370.40 nM	CDK4, IC₅₀: 644.80 nM	CDK5, IC₅₀: 3678.50 nM	CDK6, IC₅₀: 1345.50 nM	CDK7, IC₅₀: 7.21 nM		CDK9, IC₅₀: 704.3 nM
CDK2-IN-41		CDK2
A-1592668									CDK9
CDK7-IN-6							CDK7, IC₅₀: ≤100 nM
CDK2/4-IN-1		CDK2		CDK4
CDK2/4 ligand 1		CDK2		CDK4
CDK7-IN-16							CDK7, IC₅₀: 1~10 nM
CDK8-IN-6								CDK8, Kd: 13 nM
ZnPc-PEG2-VH032		CDK2
Haspin-IN-2																	CLK1, IC₅₀: 445 nM
CDK4/9-IN-1				CDK4, IC₅₀: 23 nM					CDK9, IC₅₀: 12 nM
(S)-LY3177833																Cdc7
CDK4/6-IN-23						CDK6, IC₅₀: 11 nM
CDK4/6-IN-28				CDK4, IC₅₀: 14.02 nM		CDK6, IC₅₀: 10.03 nM
CDK8-IN-17								CDK8, IC₅₀: 9 nM
CDK8/19-IN-3								CDK8							CDK19
CDK9-IN-51									CDK9
CDK2-IN-12		CDK2, IC₅₀: 11.6 μM							CDK9, IC₅₀: >12.5 μM
CDK9-IN-45	CDK1, IC₅₀: 489.5 nM								CDK9, IC₅₀: 7.13 nM
CDK7-IN-10							CDK7, IC₅₀: ＜100 nM
HDAC1/CDK7-IN-1							CDK7, IC₅₀: 893 nM
ZLMT-72		CDK2/CycA2, IC₅₀: 0.741							CDK9/CycT1, IC₅₀: 1.03
P-gp/CDK2-IN-1		CDK2
CDK2 modulator 1		CDK2/cyclinE
CDK4/6-IN-7				CDK4, IC₅₀: 1.58 nM		CDK6, IC₅₀: 4.09 nM
Multi-kinase-IN-4		CDK2, IC₅₀: 2.09 μM
Thio-acridone				Cdk4/cyclin D1, IC₅₀: 2 μM
Cdc7-IN-15																Cdc7
PF-06842874				CDK4/cyclinD1, Ki: 62 nM		cdk6/cyclin D3, Ki: 130 nM
CDKI-83	CDK1/B, Ki: 72 nM	CDK2/E, Ki: 232 nM		CDK4/D, Ki: 290 nM			CDK7/H, Ki: 405 nM		CDK9/T1, Ki: 21 nM
CDK2-IN-53		CDK2
Aloisine A	CDK1/cyclinB, IC₅₀: 0.15 μM	CDK2/cyclinA, IC₅₀: 0.12 μM CDK2/cyclinE, IC₅₀: 0.4 μM			CDK5/p35, IC₅₀: 0.16 μM
CDK7-IN-32							CDK7
CDK9-IN-28									CDK9/cyclinT1
LZ9	CDK1 cyclin B1/CDC2
LCI133				CDK4, IC₅₀: 4.7 nM		CDK6, IC₅₀: 10.2 nM			CDK9, IC₅₀: 4.1 nM
CLK1/4-IN-1																	CLK1, IC₅₀: 9.7 nM CLK4, IC₅₀: 6.6 nM
CDK9-IN-49									CDK9, IC₅₀: 7.32 nM
M1-20	CDK1
CP-07									CDK9
CDK2-IN-54		CDK2
CDK6-IN-2						CDK6, IC₅₀: 0.013 μM
Carbonic anhydrase inhibitor 14		CDK2, IC₅₀: 20.3 μM
PI3Kα-IN-26		CDK2/CycA2, IC₅₀: 3.96 μM						CDK8/cyclin C, IC₅₀: 137.20 nM
CDK4/6-IN-21 maleate				CDK4, IC₅₀: 3.88 nM		CDK6, IC₅₀: 3.31 nM
CDK4/6-IN-20				CDK4, IC₅₀: 1.9 nM		CDK6, IC₅₀: 14.2 nM
17β-HSD10/CDK5-IN-1					Cdk5/p25, IC₅₀: 0.26 μM
17β-HSD10-IN-4					Cdk5/p25
Palbociclib-C4-Boc				CDK4		CDK6
Wogonin (Standard)								CDK8
CDK9-IN-37									CDK9, EC₅₀: 5.5 nM
ALK-IN-29		CDK2
G721-0282				CDK4		CDK6																			99.96%
Multi-target kinase-IN-7		CDK2, IC₅₀: 0.314 μM
VWK147				CDK4
CDK2/4/6-IN-1		CDK2, IC₅₀: 2.5 nM		CDK4, IC₅₀: 23.7 nM		CDK6, IC₅₀: 44.3 nM
PARP1/CDK12-IN-1											CDK12, IC₅₀: 285 nM
CDK5-IN-4		CDK2, IC₅₀: 6.24 ± 2.8 μM			CDK5, IC₅₀: 9.8 ± 2.29 μM				CDK9, IC₅₀: 1.76 ± 0.3 μM
Calactin	CDK1/cyclinB1
CDK9 degrader-1									CDK9, DC₅₀: 0.4073 μM
CDK9-IN-24									CDK9
BAY-1112054 hydrochloride									CDK9
CDK8-IN-2								CDK8, IC₅₀: 0.01 μM							CDK19, IC₅₀: 0.026 μM
CDK4-IN-5				Cdk4/cyclin D1
CDK2/4/6-IN-3		CDK2		CDK4		CDK6
JAK1/CDK7-IN-1							CDK7
Indazole 1																	CLK2
CDK7 ligand 3							CDK7
Rohitukine		CDK2/A, IC₅₀: 7.5 μM							CDK9/T1, IC₅₀: 0.3 μM
CST651				CDK4, DC₅₀: 20 nM (In MM.1S cells)		CDK6, DC₅₀: 5.1 nM (In MM.1S cells)
XL413 hydrochloride																Cdc7, IC₅₀: 3.4 nM
CXJ2080							CDK7
SLM6									CDK9/cyclinT1, IC₅₀: 133 nM
RO8323								CDK8, IC₅₀: 2 nM							CDK19, IC₅₀: 3 nM
CKD-712	Cdk1/cyclin B CDK1/cyclin A
CDK2-IN-8		CDK2, IC₅₀: 1.74 μM
CDK9-IN-34									CDK9, IC₅₀: 0.25 μM
CDK9-IN-33		CDK2, IC₅₀: 316.30 nM		CDK4, IC₅₀: 1771.00 nM		CDK6, IC₅₀: >10000 nM	CDK7, IC₅₀: 160 nM		CDK9, IC₅₀: 17.44 nM
CDK9/HDAC1/HDAC3-IN-1									CDK9, EC₅₀: 0.17 μM
CDK5-IN-2		CDK2/CycA, IC₅₀: 23 nM			Cdk5/p25, IC₅₀: 0.2 nM
GSK3-IN-10				CDK4, IC₅₀: 3800 nM													CLK1, IC₅₀: 620 nM CLK4, IC₅₀: 760 nM CLK2, IC₅₀: 800 nM
Cdc7-IN-14																Cdc7, IC₅₀: <1 nM
CDK2-IN-9		CDK2, IC₅₀: 0.63 μM
CDK9-IN-50		CDK2, IC₅₀: 268.3 nM							CDK9, IC₅₀: 2.2 nM
Cdc7-IN-13																Cdc7, IC₅₀: <1 nM
TrkA Inhibitor	CDK1, IC₅₀: 3 μM	CDK2, IC₅₀: 0.69 μM
CDK11-IN-1 hydrochloride										CDK11, IC₅₀: 4 nM
CDK9-IN-19									CDK9/cyclinT1, IC₅₀: 2 nM
CDK2 degrader 9		CDK2
CDK9-IN-22		cdk2/cyclin A, IC₅₀: 876.2 nM							CDK9/cyclinT1, IC₅₀: 10.4 nM
NUAK1-IN-1				CDK4
CDK2-IN-20		CDK2/cyclinE, IC₅₀: 0.219 μM
USP10-IN-4				CDK4
CDK4/6-IN-14	CDK1, IC₅₀: >10000 nM	CDK2, IC₅₀: 1045 nM		CDK4, IC₅₀: 10 nM		CDK6, IC₅₀: 16 nM	CDK7, IC₅₀: 2595 nM		CDK9, IC₅₀: 2664 nM
CDK4/6/BRD4-IN-1				CDK4, IC₅₀: 85 nM		CDK6, IC₅₀: 106 nM
PROTAC CDK6 Degrader 2						CDK6
KWZL-7f15						CDK6, IC₅₀: 31.81 nM
CDC20/HSP90-IN-1	CDK1/cyclinB1
CDK9-IN-48									CDK9, IC₅₀: 1.37 nM
BLINK11	CDK1/Cly Y, IC₅₀: 39.34 nM	CDK2/ClyA2, IC₅₀: 83.43 nM			CDK5/p35, IC₅₀: 17.09 nM Cdk5/p25, IC₅₀: 14.69 nM				cdk9-cyclin T, IC₅₀: 83.43 nM
IIIM-290		CDK2/A, IC₅₀: 90 nM							CDK9/T1, IC₅₀: 94 nM
Dalpiciclib isethionate				CDK4		CDK6
CDK4/6/HDAC-IN-1	CDK1, IC₅₀: 55.6 nM			CDK4, IC₅₀: 7.23 nM		CDK6, IC₅₀: 13.2 nM CDK6, IC₅₀: 48.38 nM
CDK/HDAC-IN-2	CDK1, IC₅₀: 8.63 nM	CDK2, IC₅₀: 0.30 μM		CDK4, IC₅₀: >1000 nM		CDK6, IC₅₀: >1000 nM	CDK7, IC₅₀: >1000 nM
CDK8-IN-10								CDK8, IC₅₀: 8.25 nM
ZLHQ-5f		CDK2/CycA2, IC₅₀: 0.145 μM
CLK1/4-IN-2																	CLK1, IC₅₀: 7 nM CLK4, IC₅₀: 2.3 nM
CDK9-IN-46									CDK9
CDK9-IN-42									CDK9, IC₅₀: 3.8 nM
CDK9-IN-40									CDK9, IC₅₀: 5.5 nM
CDK4/6-IN-16				CDK4, IC₅₀: 13 nM
YY173				CDK4, IC₅₀: 7.7 nM		CDK6, IC₅₀: 88 nM
CDK9-IN-52									CDK9
KDM1/CDK1-IN-1	CDK1, IC₅₀: 0.078 ± 2. μM
CDK2-IN-43		Cdk2/cyclin E2, IC₅₀: 6 nM
CDK12/13 ligand 2											CDK12	CDK13
WWZ-11-098						CDK6, DC₅₀: 2.6 nM
CDK2-IN-36		CDK2
CDK12/13-IN-2											CDK12, IC₅₀: 15.5 nM	CDK13, IC₅₀: 12.2 nM
ARUK2010489		CDK2		CDK4		CDK6
CDK2-IN-18		CDK2/cyclinE, IC₅₀: 8 nM		Cdk4/cyclin D1, IC₅₀: 46 nM
CDK2/9-IN-1		CDK2, IC₅₀: 0.004 μM							CDK9, IC₅₀: 0.009 μM
EGFR/CDK2-IN-5		CDK2, IC₅₀: 212.10 nM
CDK7-IN-20	CDK1, IC₅₀: 3375 nM	CDK2, IC₅₀: 823 nM	CDK3, IC₅₀: 1837 nM		CDK5, IC₅₀: >10,000 nM	CDK6, IC₅₀: 950 nM	CDK7, IC₅₀: 4 nM		CDK9, IC₅₀: 526 nM		CDK12, IC₅₀: >10,000 nM
CDK9 ligand 4									CDK9
CDK9 autophagic degrader 1									CDK9
CDK8-IN-7								CDK8, Kd: 3.5 nM
Carbonic anhydrase inhibitor 33						CDK6, IC₅₀: 0.069 μM
NU6310		CDK2, IC₅₀: 0.16 μM
CDK2-IN-47	CDK1, IC₅₀: 1.80 μM	CDK2, IC₅₀: 0.21 μM		CDK4, IC₅₀: > 10 μM		CDK6, IC₅₀: > 10 μM	CDK7, IC₅₀: 8.70 μM		CDK9, IC₅₀: 2.30 μM
KRAS G13D-IN-2						CDK6
CDK2-IN-7		CDK2/cyclinE, IC₅₀: 50 nM
CDK4/6-IN-21				CDK4, IC₅₀: 3.88 nM		CDK6, IC₅₀: 3.31 nM
SHP2/CDK4-IN-1				CDK4, IC₅₀: 18.2 ± 1.3 nM
CDK2-IN-55	CDK1, IC₅₀: 26.3 nM	CDK2, IC₅₀: 4.7 nM							CDK9, IC₅₀: 288 nM																98.91%
CDK8-IN-5								CDK8, IC₅₀: 72 nM
Anticancer agent 30		CDK2
BMI-1026	CDK1, IC₅₀: 2.3 nM
CDK-IN-14		CDK2/CycA2, IC₅₀: 0.097 μM
PROTAC BET Degrader-15						CDK6
Cdc7-IN-18																Cdc7, IC₅₀: 1.29 nM
CDK8-IN-20							CDK7, IC₅₀: 726.9 nM	CDK8, IC₅₀: 70.5 nM	CDK9, IC₅₀: 217.4 nM						CDK19, IC₅₀: 147.8 nM
CDK2-IN-57		CDK2/Cyc E, IC₅₀: 2.8 nM
AP4-43																	CLK1 CLK4
PC8						CDK6, IC₅₀: 0.197 μM
CAIX/CDK-2-IN-1		CDK2, IC₅₀: 0.32 μM
CDK1-IN-8	CDK1
Cdc7-IN-12																Cdc7, IC₅₀: <1 nM
CDK11A Human Pre-designed siRNA Set A																								PITSLRE
KB-0742 hydrochloride	CDK1/cyclin A, IC₅₀: 2980 nM	cdk2/cyclin A, IC₅₀: 397 nM	CDK3/Cyclin E, IC₅₀: 1420 nM	Cdk4/cyclin D1, IC₅₀: 3130 nM	Cdk5/p25, IC₅₀: 1820 nM	CDK6/cycD1, IC₅₀: 3950 nM	CDK7/cyclin H, IC₅₀: 1510 nM	CDK8/cyclin C, IC₅₀: >10000 nM	CDK9/cyclinT1, IC₅₀: 6 nM
CDK4/6-IN-27				CDK4		CDK6
EF-4-177		CDK2/cyclinE, IC₅₀: 87 nM
SZ-015268							CDK7, IC₅₀: 23.56 nM
PROTAC CDK9 degrader-6									CDK9₄₂, DC₅₀: 0.03 μM CDK9₅₅, DC₅₀: 0.05 μM
CDK2-IN-48	CDK1, IC₅₀: > 1 μM	CDK2, IC₅₀: < 0.05 μM
KI-ARv-03									CDK9, IC₅₀: 0.15 μM
CDK6 ligand-Linker Conjugate 1						CDK6
CDK2-IN-50		CDK2/cyclinE, IC₅₀: 0.77 nM
PROTAC CDK9/CycT1 Degrader-2									CDK9, IC₅₀: 45 nM
ARUK2010694		CDK2		CDK4		CDK6
VCC972839:01									CDK9, IC₅₀: 7 nM
CLK1/2-IN-3																	CLK1, IC₅₀: 1.1 nM CLK2, IC₅₀: 2.1 nM
FLT3/ITD-IN-4														CDK16/Cyclin Y, EC₅₀: 1768 nM
Multi-kinase-IN-7		CDK2, IC₅₀: 9.31 μM			CDK5, IC₅₀: 23.4 μM
PSTAIR																CDC28
BLINK15	CDK1/Cly Y, IC₅₀: 35.84 nM	CDK2/ClyA2, IC₅₀: 44.12 nM			CDK5/p35, IC₅₀: 29.34 nM Cdk5/p25, IC₅₀: 12.08 nM				CDK9/Cyclin T, IC₅₀: 74.63 nM
Contragestazol				CDK4
CDK9-IN-41									CDK9, IC₅₀: 192.81 nM																98.84%
PKMYT1-IN-12	CDK1
CDK2-IN-29		CDK2, IC₅₀: 96 nM		CDK4, IC₅₀: 360 nM
CDK8-IN-19		CDK2/CycA2, IC₅₀: 1.13 μM						CDK8/cyclin C, IC₅₀: 25.08 nM
Autophagy agonist-1				CDK4
3-Methylthienyl-carbonyl-JNJ-7706621	CDK1/cyclinB, IC₅₀: 6.4 nM	CDK2/cyclinA, IC₅₀: 2 nM		CDK4, IC₅₀: 0.11 μM
CDK7-IN-8							CDK7, IC₅₀: 54.29 nM
Cdc7-IN-19																Cdc7, IC₅₀: 1.49 nM
SY-5102							CDK7, Kd: 0.03 nM
CDK2/PIM1-IN-1		CDK2, IC₅₀: 0.27 μM
CDK7-IN-15							CDK7, IC₅₀: 10-100 nM
MG16						CDK6
BMS-357075	CDK1/cyclinB1, IC₅₀: 18 nM	CDK2/cyclinE, IC₅₀: 3 nM		CDK4/cyclin D, IC₅₀: 26 nM
Dimethyl bisphenolate	CDK1/cyclinB1
ZLWT-37		CDK2, IC₅₀: 0.054 μM							CDK9, IC₅₀: 0.002 μM
PI3Kα-IN-33	CDK1/cyclinB1
RLY-2139		CDK2
ZDLD13				CDK4/CycD3, IC₅₀: 0.38 μM
CDK1/2/4-IN-1	CDK1, IC₅₀: 1.47	CDK2, IC₅₀: 0.78		CDK4, IC₅₀: 0.87
CIRc-014	Cdk1/cyclin B, Kd: 1 nM	cdk2/cyclin A, IC₅₀: 0.05 μM cdk2/cyclin A, Kd: 2.7 nM
Antitumor agent-174	CDK1/cyclinB1
PRT3645				CDK4, IC₅₀: <20 nM		CDK6, IC₅₀: <20 nM
CGP-74514 hydrochloride	CDK1/cyclinB1, IC₅₀: 25 nM
SR-2890				Cdk4/cyclin D1, IC₅₀: 283 nM Cdk4/cyclin D3, IC₅₀: 368 nM
JD128				CDK4		CDK6
GW780056X											CDK12
CDK8-IN-18								CDK8, IC₅₀: 43 μM
Anticancer agent 29	CDK1/cyclinB1, IC₅₀: 0.127 μM	CDK2/cyclinE, IC₅₀: 0.054 μM		CDK4, IC₅₀: 0.129 μM		CDK6, IC₅₀: 0.396 μM
GIT1-IN-1	CDK1/cyclinB1
CDK7/9-IN-1							CDK7, IC₅₀: 5.74-65.6 nM		CDK9, IC₅₀: 2.14 μM
CDK12-IN-7		CDK2, IC₅₀: 196 nM									CDK12, IC₅₀: 42 nM
Tubulin-IN-65	CDK1
CDK19 Probe 1															CDK19, IC₅₀: 1.01 μM
CDK12-IN-4		CDK2/cyclinE, IC₅₀: >20 μM							CDK9/cyclinT1, IC₅₀: >20 μM		CDK12, IC₅₀: 0.641 μM
Anticancer agent 264	CDK1/cyclinB1	CDK2/cyclinE
NU6301		CDK2
Ulecaciclib		cdk2/cyclin A, Ki: 0.62 μM		Cdk4/cyclin D1, Ki: 0.2 nM		cdk6/cyclin D3, Ki: 3 nM	cdk7-cyclin H, Ki: 0.63 μM
CDK12-IN-9		CDK2, IC₅₀: 551 nM					CDK7, IC₅₀: 1491 nM		CDK9, IC₅₀: 466 nM		CDK12, IC₅₀: 2.2 nM	CDK13, IC₅₀: 13 nM
CDK2-IN-28		CDK2, Ki: 1 nM ([1])			CDK5, Ki: 15.8 nM ([1])		CDK7, Ki: 54.7 nM ([1])		CDK9, Ki: 12.8 nM ([1])
WEE1/PKMYT1-IN-4	CDK1, IC₅₀: 4.9 nM
NUAK1-IN-2		CDK2		CDK4		CDK6
CDK9-IN-44									CDK9, IC₅₀: 7.6 μM
CDK2-IN-51		CDK2, IC₅₀: 23.47 nM CDK2, Ki: 4.11 μM
PROTAC CDK9 degrader-8									CDK9, IC₅₀: 0.01 μM
PROTAC CDK6 ligand 2						CDK6
SR-5037											CDK12, IC₅₀: 31 nM CDK12/Cyclin K, IC₅₀: 58.7 nM CDK12/Cyclin K, Kd: 139 nM	CDK13/Cyclin K, IC₅₀: 234.6 nM													99.58%
CDK4/6-IN-26				CDK4		CDK6
PROTAC CDK4/6/9 degrader 2				CDK4		CDK6			CDK9
UNPD139734	CDK1
CDK7-IN-31							CDK7, Kd: 0.18 nM
PROTAC CDK9 degrader-12									CDK9, : 23 nM
AG-12286	Cdk1/cyclin B, IC₅₀: 2 nM	CDK2/cyclinE, IC₅₀: 6 nM		CDK4/cyclin D, IC₅₀: 12 nM
CGP-74514 dihydrochloride	CDK1/cyclinB1, IC₅₀: 25 nM
PKMYT1-IN-13	CDK1, IC₅₀: 8.7 nM
CDK9-IN-32									CDK9
CDK4/6-IN-8				CDK4, IC₅₀: 5.01 nM		CDK6, IC₅₀: 3.97 nM
Indirubin-3'-monoxime-5-sulphonic acid	CDK1, IC₅₀: 5 nM				CDK5, IC₅₀: 7 nM
CDK7-IN-33							CDK7
Multi-kinase-IN-6		CDK2, IC₅₀: 0.71 μM
CLZX-205									CDK9, IC₅₀: 2.9 nM
CDK9-IN-23									CDK9, IC₅₀: <20 nM
EGFR-IN-45		CDK2, IC₅₀: 1.6 μM
CDK-IN-9		CDK2/E, IC₅₀: 4 nM			Cdk5/p25, IC₅₀: 39 nM				CDK9/T1, IC₅₀: 20 nM		CDK12/K, IC₅₀: 64 nM	CDK13/K, IC₅₀: 22 nM
PROTAC CDK2/4/6 Degrader-1		CDK2/cyclinE		CDK4		CDK6
PROTAC CDK4/6/9 degrader 1				CDK4, DC₅₀: 0.71 nM (MDA-MB-231 cells) CDK4, DC₅₀: 0.79 nM (CAL51 cells)		CDK6, DC₅₀: 0.44 nM (MDA-MB-231 cells) CDK6, DC₅₀: 0.61 nM (CAL51 cells)			CDK9, DC₅₀: 0.52 nM (MDA-MB-231 cells) CDK9, DC₅₀: 0.51 nM (CAL51 cells)
Aloisine RP106	Cdk1/cyclin B, IC₅₀: 0.7 μM				Cdk5/p25, IC₅₀: 1.5 μM
PARP1-IN-50	Cdk1/cyclin B
Indirubin-5-sulfonate	Cdk1/cyclin B, IC₅₀: 55 nM	cdk2/cyclin A, IC₅₀: 35 nM CDK2/cyclinE, IC₅₀: 150 nM		Cdk4/cyclin D1, IC₅₀: 300 nM	CDK5/p35, IC₅₀: 65 nM
PROTAC CDK9 degrader-5									CDK9₄₂, DC₅₀: 0.10 μM CDK9₅₅, DC₅₀: 0.14 μM
CDK1-IN-9	CDK1/cyclinB1, IC₅₀: 5.5 nM	CDK2/cyclinE, IC₅₀: 25.9 nM		CDK4/cyclin D, IC₅₀: 402.8 nM
CDK2-IN-42											CDK12
Cyclin K degrader 2	CDK1								CDK9
CDK4/6-IN-19				CDK4, IC₅₀: 0.2 nM		CDK6, IC₅₀: 5.0 nM
HS-36	CDK1, IC₅₀: > 500 nM	CDK2, IC₅₀: 197.3 nM		CDK4, IC₅₀: 18.9 nM		CDK6, IC₅₀: 125.5 nM	CDK7, IC₅₀: > 500 nM		CDK9, IC₅₀: 4.2 nM CDK9, IC₅₀: 216.9 nM		CDK12, IC₅₀: > 500 nM
CDK2-IN-15		CDK2, IC₅₀: 2.9 μM
CDK7-IN-7							CDK7, IC₅₀: <50 nM
CDK8-IN-15								CDK8, IC₅₀: 57 nM
YJZ5118											CDK12, IC₅₀: 39.5 nM	CDK13, IC₅₀: 26.4 nM
CDK4-IN-4				human CDK4
CDK7-IN-5							CDK7, IC₅₀: <100 nM
CDK12/13 ligand 3											CDK12	CDK13
CDK6/9-IN-2						CDK6, IC₅₀: 15 nM			CDK9, IC₅₀: 22 nM
LS-Q2	CDK1, IC₅₀: 1249 nM	CDK2, IC₅₀: 1491 nM		CDK4, IC₅₀: 1.4 nM	CDK5, IC₅₀: 795 nM	CDK6, IC₅₀: 52 nM	CDK7, IC₅₀: 748 nM	CDK8, IC₅₀: >10000 nM	CDK9, IC₅₀: 6.2 nM
Apoptosis inducer 50	CDK1
CDK2-IN-45		CDK2, IC₅₀: 0.64 μM
Haspin-IN-1																	CLK1, IC₅₀: 221 nM
CDK2-IN-52		CDK2, DC₅₀: 1-10 nM
CDK4/6-IN-10				CDK4, IC₅₀: 22 nM		CDK6/cyclinD1, IC₅₀: 10 nM
FKA-9i	CDK1
CDK9-IN-36									CDK9, IC₅₀: 1.2 nM
CDK7-IN-29							CDK7, IC₅₀: 1.4 nM
MRTX849-amide-C4-(o)-carborane				Cdk4/cyclin D1
CDK9/PARP-IN-1									CDK9, IC₅₀: 118 nM
CDK9 ligand 5									CDK9
CDK2-IN-44		CDK2
AG-012986 dihydrochloride	CDK1, Ki: 44 nM	CDK2, Ki: 94 nM	CDK3/Cyclin E, Ki: 46 nM	Cdk4/cyclin D3, Ki: 9.2 nM	CDK5/p35, IC₅₀: 22 nM		CDK7/cyclin H, Ki: 0 nM		CDK9/CycT1, IC₅₀: 4 nM
ARN25499																Cdc42
CDK2-IN-56		cdk2/cyclin A
CDK2-IN-14-d₃		CDK2
CDK7-IN-27		CDK2, IC₅₀: 19.4 nM					CDK7, IC₅₀: 3 nM
UNC10112785		CDK2, IC₅₀: 0.016 μM		CDK4, IC₅₀: 1.99 μM
Avotaciclib sulfate	CDK1
Anticancer agent 298		CDK2
FLT3/CDK4-IN-1				CDK4, IC₅₀: 7 nM
VEGFR2-IN-86		CDK2, IC₅₀: 0.78 μM
CDK2-IN-59		CDK2/CycA2, IC₅₀: 66.33 μM
Isosilybin B (Standard)		CDK2		CDK4
CDK12/13 ligand 1											CDK12	CDK13
CDK1-IN-4	CDK1, IC₅₀: 44.52 nM	CDK2, IC₅₀: 621.93 nM			CDK5, IC₅₀: 135.22 nM
BRD4/AKT-IN-1		CDK2/cyclin E1
VEGFR-2-IN-69		CDK2		CDK4		CDK6
PROTAC CDK2-pRb degrader-1		CDK2/cyclinE
CDK7 ligand 3-CO-C5-COOH							CDK7
CDK8/19-IN-2								CDK8/CycC, IC₅₀: 2.08 nM							CDK19/CycC, IC₅₀: 2.49 nM
Alisol B 23-acetate (Standard)				CDK4		CDK6
JTK-101									CDK9/cyclinT1
CDK2-IN-27	CDK1/cyclinB1, IC₅₀: >10-20 nM nM	CDK2/cyclin E1, IC₅₀: <10 nM
BDE30671203	CDK1
Tabersonine hydrochloride				CDK4																					98.55%
2-Cyanoethylalsterpaullone	Cdk1/cyclin B, IC₅₀: 0.23 nM
Cdk18 Rat Pre-designed siRNA Set A																						CDK18
Cdk20 Rat Pre-designed siRNA Set A																							CDK20
MG-002				Cdk4/cyclin D1
Cdk15 Rat Pre-designed siRNA Set A																				CDK15
CCT68127		CDK2					CDK7		CDK9
Antitrypanosomal agent 31		human CDK2, pIC₅₀: 6.9		human CDK4, pIC₅₀: 7.1
CDK8-IN-16								CDK8, IC₅₀: 5.1 nM							CDK19, IC₅₀: 5.6 nM
CDK2-IN-58		CDK2, IC₅₀: 0.21 μM
Cdk10 Mouse Pre-designed siRNA Set A																			CDK10
RO0505124				CDK4, IC₅₀: 20 nM
CDK2-IN-21		CDK2/cyclinE, IC₅₀: 0.24 μM

Name
Email *

	Sorry, but the email address you supplied was invalid.